Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| puried from postmenopausal women, mixture of FSH and LH |
|
|
Term
|
Definition
| purified human follicle stimulating hormone |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| SHBG, alpha and beta receptors. Bind to EREs |
|
|
Term
|
Definition
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
| progesterone; bind to nuclear receptors (transcription factors) and regular gene expression; carbohydrate metabolism |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| SERM; similar to Tamoxifen |
|
|
Term
|
Definition
| SERM; inhibits estrogen neg. feedback inhibition of FSH and LH release; may exhibit anti estrogen effects on uterus and cervix |
|
|
Term
|
Definition
| estrogen antagonist; treatment of breast cancer |
|
|
Term
|
Definition
| aromatase inhibitors (AI); used in adjunct treatment in ER positive breast cancer |
|
|
Term
|
Definition
| aromatase inhibitors (AI); used in adjunct treatment in ER positive breast cancer |
|
|
Term
|
Definition
| aromatase inhibitors (AI); used in adjunct treatment in ER positive breast cancer |
|
|
Term
|
Definition
| anti-progesterone; inhibits progesterone; early termination of pregnancy |
|
|
Term
|
Definition
| inhbits FSH and LH; used for endometriosis, and fibrocyctic breast disease |
|
|
Term
|
Definition
| androgen; anabolic agent that is converted via 5- alpha rectase |
|
|
Term
|
Definition
| androgen replacement therapy |
|
|
Term
|
Definition
| anabolic steroid for anemia, bone pain in osteoporsis, and increasing weight (androgen receptor agonits) |
|
|
Term
|
Definition
| anabolic steroid for anemia, bone pain in osteoporsis, and increasing weight (androgen receptor agonits) |
|
|
Term
|
Definition
| anabolic steroid for anemia, bone pain in osteoporsis, and increasing weight (androgen receptor agonits) |
|
|
Term
|
Definition
| anabolic steroid for anemia, bone pain in osteoporsis, and increasing weight (androgen receptor agonits) |
|
|
Term
|
Definition
| antifungal; inhibit steroid synthesis (anti-androgen) |
|
|
Term
|
Definition
| 5-alpha reductase inhibitor; male pattern baldness; type II |
|
|
Term
|
Definition
| 5-alpha reductase inhibitor; equal for type I and II |
|
|
Term
|
Definition
| androgen receptor blocker; blockers androgen receptors in prostate to reduce growth and treat metastatic prostate cancer |
|
|
Term
|
Definition
| androgen receptor blocker; blockers androgen receptors in prostate to reduce growth and treat metastatic prostate cancer |
|
|
Term
|
Definition
| androgen receptor blocker; blockers androgen receptors in prostate to reduce growth and treat metastatic prostate cancer |
|
|
Term
|
Definition
| steroid androgen receptor antagonist |
|
|
Term
|
Definition
| alkylating agent; widest spectrum of nitrogen mustards; activated by CYP450 to active metbolite--bladder toxcity |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| antracycline antiobiotics; inhibits topoisomerase leading to DNA beaks and release of free radicals |
|
|
Term
|
Definition
| antracycline antiobiotics; inhibits topoisomerase leading to DNA beaks and release of free radicals |
|
|
Term
|
Definition
| antracycline antiobiotics; inhibits topoisomerase leading to DNA beaks and release of free radicals |
|
|
Term
|
Definition
| antracycline antiobiotics; inhibits topoisomerase leading to DNA beaks and release of free radicals |
|
|
Term
|
Definition
| antedote for anthracycline toxicity |
|
|
Term
|
Definition
| antidote for anthracycline induced cardiomyopathy; iron chelator |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
